A Study of Hospital-at-Home for People Receiving Tarlatamab

Clinical trial NCT06957314 · RECRUITING

Trial details

NCT number: NCT06957314
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Small-cell Lung Cancer Small Cell Lung Carcinoma

Start date: 2025-04-23
Primary completion: 2028-04-23
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.